Cigna Group $CI Shares Purchased by ProShare Advisors LLC

ProShare Advisors LLC boosted its position in Cigna Group (NYSE:CIFree Report) by 13.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 54,247 shares of the health services provider’s stock after purchasing an additional 6,332 shares during the quarter. ProShare Advisors LLC’s holdings in Cigna Group were worth $14,930,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Beacon Financial Strategies CORP acquired a new stake in Cigna Group during the 4th quarter worth $28,000. Lodestone Wealth Management LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at about $32,000. Collier Financial purchased a new position in shares of Cigna Group in the third quarter worth about $34,000. Activest Wealth Management boosted its position in Cigna Group by 1,050.0% during the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after acquiring an additional 126 shares during the last quarter. Finally, Entrust Financial LLC acquired a new position in Cigna Group during the fourth quarter worth about $42,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 2.7%

Shares of NYSE CI opened at $283.36 on Thursday. The company has a market capitalization of $74.96 billion, a P/E ratio of 12.01, a P/E/G ratio of 1.02 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company has a 50 day simple moving average of $275.73 and a 200-day simple moving average of $275.77. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89.

Cigna Group (NYSE:CIGet Free Report) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the firm posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts predict that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio is 26.45%.

Analyst Upgrades and Downgrades

A number of research firms have commented on CI. Jefferies Financial Group cut their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a report on Monday, April 20th. Royal Bank Of Canada boosted their target price on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a report on Friday, May 1st. Morgan Stanley increased their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday. Raymond James Financial set a $340.00 price objective on Cigna Group in a research report on Friday, May 1st. Finally, Truist Financial boosted their price objective on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $338.55.

Read Our Latest Research Report on CI

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is currently owned by company insiders.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.